Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Green Alert

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Feb 10, 2022 3:04pm

178 Views

Post# 34417803

RE:RE:RE:RE:Green Alert

agree 100% that the company needs to build credibility as that would open the door for other companies to take a closer look.
Trying not to get too excited yet as we have seen this kind of price run before so it needs to hold and build a stronger base and support level. This will help for more people and institutions to take a look.
What I do like is the increased volume with the rise in share price and will be real interesting to see how the sp closes and holds up tomorrow. Cautiously optimistic I am.

<< Previous

Bullboard Posts

Next >>

Odd Burger to add 40 locations in Florida